Advicenne Pharma
Latest round
- Series C
Last raised
- May 2017
Total raised
- $27M
Investors
- 6
About Advicenne Pharma
Founded in 2007, Advicenne Pharma SA operates from Nimes, France, and is dedicated to addressing the unmet medical needs of patients with rare renal conditions. The company's founder, Didier Laurens, has a history of leading ventures in the pharmaceutical sector.Advicenne specializes in the development and commercialization of innovative pharmaceuticals aimed at addressing the needs of patients suffering from rare renal diseases. Their flagship product, Sibnayal®, combines potassium citrate and potassium bicarbonate to provide a therapeutic solution for patients with Distal Renal Tubular Acidosis (dRTA). Approved in 2021 by both the European Medicine Agency and the UK's MHRA, Sibnayal® is specifically designed to improve metabolic health and manage symptoms associated with rare renal conditions, thereby enhancing the quality of life for users. Advicenne's products are available in multiple geographical markets, including various European nations and the United States, catering to both pediatric and adult patients who have limited therapeutic options.30 in the most recent year, 2023. This revenue is primarily derived from the sales of its pharmaceutical products, including Sibnayal®. The company engages in business-to-business transactions with healthcare providers and partners with pharmaceutical distributors to enhance market penetration.Advicenne plans to expand its product offerings and market presence. The company is focusing on the development of additional treatments for rare renal diseases to enhance its portfolio. Furthermore, Advicenne aims to penetrate new geographic markets, particularly targeting regions where there is a high demand for effective renal therapies.
Who invested in Advicenne Pharma
6 investors across 3 rounds
See all investors in Advicenne Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Advicenne Pharma
Who invested in Advicenne Pharma?
Advicenne Pharma has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Advicenne Pharma raised?
Advicenne Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Advicenne Pharma last raise money?
Advicenne Pharma's most recent round on record is a Series C, in May 2017.
What does Advicenne Pharma do?
Founded in 2007, Advicenne Pharma SA operates from Nimes, France, and is dedicated to addressing the unmet medical needs of patients with rare renal conditions.
Where is Advicenne Pharma headquartered?
Advicenne Pharma is headquartered in Nimes, France.
Which VCs invest in companies like Advicenne Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Advicenne Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Advicenne Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.